. Author manuscript; available in PMC: 2021 May 14.

Published in final edited form as: Dev Comp Immunol. 2020 Aug 29;114:103843. doi: 10.1016/j.dci.2020.103843

Table 2.

Setup for Experiment 2

Treatment (day -2)^†	Challenge	Designation	N
Mock (PBS + DMSO)	Mock	Mock/Mock	4
αGalCer (i.m.)	Mock	αGC i.m./Mock	6
Mock (PBS + DMSO)	CA04 H1N1	Mock/CA04	6
αGalCer (i.n)	CA04 H1N1	αGC i.n./CA04	6

^†

Treatments were was administered 2 days before virus infection.